Skip to main content
High RiskFDAfda-F-0781-2021UNDECLARED ALLERGEN

Living Free Nerve & Muscle Plus Cetyl-Myristoleate Herbal and Glandular Supplement, 180 and 500 capsules per bottles. Product is packed ...

Units Affected
0
Recall Date
June 21, 2021
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0781-2021.

Label declares lecithin but does not declare soy lecithin.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0781-2021.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Bea Lydeckers Naturals Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0781-2021.

Bea Lydeckers Naturals Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Bea Lydeckers Naturals Inc Recall FAQ

Bea Lydeckers Naturals Inc is the subject of a baby food & formula safety report: Living Free Nerve & Muscle Plus Cetyl-Myristoleate Herbal and Glandular Supplement, 180 and 500 capsules per bottles. Product is packed .... The notice was published on June 21, 2021 by the U.S. Food and Drug Administration (FDA). Approximately 0 units are potentially affected.